# Eric K. Rowinsky

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eric-k-rowinsky/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,369 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 89 |
| i10-index | 299 |
| Last Known Institution | Development Services Group (United States) |
| OpenAlex ID | https://openalex.org/A5011905014 |
| ORCID iD | https://orcid.org/0000-0002-0848-4826 |
| Works | 480 |

## Researcher papers

- [Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.](https://scholariq.org/papers/taxol-inhibits-neointimal-smooth-muscle-cell-accumulation-after-angioplasty-in/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Development Services Group (United States)](https://scholariq.org/institutions/development-services-group-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.